PRECISION BIOSCIENCES INC (DTIL) Free cash flow 2018–2025
PRECISION BIOSCIENCES INC (DTIL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$65.9MFY2025 · since FY2018: -$66.0M → -$65.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$65.9M | -12.3% |
| FY2024 | -$58.7M | +31.8% |
| FY2023 | -$86.1M | -75.4% |
| FY2022 | -$49.1M | -208.5% |
| FY2021 | -$15.9M | +82.8% |
| FY2020 | -$92.4M | +3.4% |
| FY2019 | -$95.7M | -45.0% |
| FY2018 | -$66.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More DTIL financial trends
DTIL RevenueDTIL Net incomeDTIL Net marginDTIL Gross profitDTIL Gross marginDTIL Operating incomeDTIL Operating marginDTIL Operating cash flowDTIL Capital expendituresDTIL Return on equityDTIL Stock buybacksDTIL Dividends paidDTIL Total assetsDTIL Total liabilitiesDTIL Shareholders’ equityDTIL overview →